Free Trial

Inuvo (NYSE:INUV) Coverage Initiated at StockNews.com

Inuvo logo with Computer and Technology background

Stock analysts at StockNews.com started coverage on shares of Inuvo (NYSE:INUV - Get Free Report) in a note issued to investors on Tuesday. The brokerage set a "hold" rating on the stock.

Separately, HC Wainwright reaffirmed a "buy" rating and issued a $2.00 price target on shares of Inuvo in a research note on Tuesday, May 13th.

Check Out Our Latest Analysis on Inuvo

Inuvo Stock Performance

Shares of NYSE:INUV opened at $0.53 on Tuesday. The company's fifty day moving average is $0.39 and its 200-day moving average is $0.40. The company has a market capitalization of $76.02 million, a PE ratio of -8.78 and a beta of 0.98. Inuvo has a 52 week low of $0.19 and a 52 week high of $0.79.

Inuvo (NYSE:INUV - Get Free Report) last issued its quarterly earnings results on Friday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). Inuvo had a negative net margin of 10.59% and a negative return on equity of 57.24%. During the same quarter in the prior year, the business posted ($0.01) EPS. On average, analysts forecast that Inuvo will post -0.02 EPS for the current year.

Hedge Funds Weigh In On Inuvo

A number of large investors have recently bought and sold shares of the company. Perkins Capital Management Inc. boosted its position in Inuvo by 3.7% during the 4th quarter. Perkins Capital Management Inc. now owns 7,083,452 shares of the company's stock worth $4,579,000 after acquiring an additional 255,590 shares during the last quarter. Geode Capital Management LLC boosted its position in Inuvo by 12.6% during the 4th quarter. Geode Capital Management LLC now owns 1,203,887 shares of the company's stock worth $778,000 after acquiring an additional 134,497 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in Inuvo by 9.3% during the 4th quarter. Renaissance Technologies LLC now owns 507,149 shares of the company's stock worth $328,000 after acquiring an additional 43,349 shares during the last quarter. Institutional investors and hedge funds own 29.36% of the company's stock.

About Inuvo

(Get Free Report)

Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). Its platforms optimize the purchase and placement of advertising in real time.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Inuvo Right Now?

Before you consider Inuvo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inuvo wasn't on the list.

While Inuvo currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines